메뉴 건너뛰기




Volumn 23, Issue 9, 2007, Pages 23-26

Paediatric dosing guidelines should integrate the four most important developmental pharmacokinetic processes
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

EID: 34548062894     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-200723090-00007     Document Type: Review
Times cited : (1)

References (8)
  • 1
    • 33750380248 scopus 로고    scopus 로고
    • Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations
    • Bartelink IH, Rademaker CMA, Schobben AFAM, et al. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006; 45 (11): 1077-97
    • (2006) Clin Pharmacokinet , vol.45 , Issue.11 , pp. 1077-1097
    • Bartelink, I.H.1    Rademaker, C.M.A.2    Schobben, A.F.A.M.3
  • 2
    • 31344444671 scopus 로고    scopus 로고
    • Prediction of cytochrome P450-mediated hepatic drug clearance in neonates, infants and children: How accurate are available scaling methods?
    • Bjorkman S. Prediction of cytochrome P450-mediated hepatic drug clearance in neonates, infants and children: how accurate are available scaling methods? Clin Pharmacokinet 2006; 45 (1): 1-11
    • (2006) Clin Pharmacokinet , vol.45 , Issue.1 , pp. 1-11
    • Bjorkman, S.1
  • 4
    • 1842482906 scopus 로고    scopus 로고
    • Pediatric pharmacokinetic data: Implications for environmental risk assessment for children
    • Ginsberg G, Hattis D, Miller M, et al. Pediatric pharmacokinetic data: implications for environmental risk assessment for children. Pediatrics 2004; 113 (4): 973-83
    • (2004) Pediatrics , vol.113 , Issue.4 , pp. 973-983
    • Ginsberg, G.1    Hattis, D.2    Miller, M.3
  • 5
    • 0034532246 scopus 로고    scopus 로고
    • Impact of developmental pharmacology on pediatric study design; overcoming the challenges
    • Kearns GL. Impact of developmental pharmacology on pediatric study design; overcoming the challenges. J Allergy Clin Immunol 2000; 106: S128-39
    • (2000) J Allergy Clin Immunol , vol.106
    • Kearns, G.L.1
  • 6
    • 17844365096 scopus 로고    scopus 로고
    • Intramuscular injections in children [in German]
    • Apr;
    • Hunseler C, Roth B, Pothmann R, et al. Intramuscular injections in children [in German]. Schmerz 2005 Apr; 19 (2): 140-3
    • (2005) Schmerz , vol.19 , Issue.2 , pp. 140-143
    • Hunseler, C.1    Roth, B.2    Pothmann, R.3
  • 7
    • 0026729372 scopus 로고
    • Disposition of antine oplastic agents in the very young child: Pharmacokinetics in children
    • McLeod HL, Relling MV, Crom WR, et al. Disposition of antine oplastic agents in the very young child: pharmacokinetics in children. Br J Cancer Suppl 1992; 18: S23-9
    • (1992) Br J Cancer Suppl , vol.18
    • McLeod, H.L.1    Relling, M.V.2    Crom, W.R.3
  • 8
    • 1642502349 scopus 로고    scopus 로고
    • Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates
    • Kimura T, Sunakawa K, Matsuura N, et al. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates. Antimicrob Agents Chemother 2004; 48 (4): 1159-67
    • (2004) Antimicrob Agents Chemother , vol.48 , Issue.4 , pp. 1159-1167
    • Kimura, T.1    Sunakawa, K.2    Matsuura, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.